VK2735

VK2735, a dual GIP/GLP-1 receptor agonist peptide

N/A Amino Acids · MW: N/A

Ask AI About This

Amino Acids

N/A

Molecular Weight

N/A

Half-life

approximately 5-7 days

Research Score

4.7

Studies

Storage

Store lyophilized at -20°C, reconstituted at 2-8°C

What is VK2735?

VK2735 is a dual incretin peptide developed for obesity and metabolic disease, with both injectable and oral development programs reported in the literature. It is intended to reduce appetite, improve glycemic control, and support clinically meaningful weight loss.

Key Benefits & Mechanisms

weight loss

improved glucose control

reduced appetite

weekly or oral dosing potential

Research Summary

Early clinical data suggest VK2735 can produce rapid weight reduction with a tolerability profile consistent with incretin therapy. Research is now centered on comparing injectable and oral formulations and defining the best dose range.

Related Peptides

RgIA

alpha-Conotoxin RgIA from Conus regius venom

RgIA is a disulfide-rich cone snail peptide that selectively antagonizes the alpha9alpha10 nicotinic acetylcholine receptor. It is used as a research tool in pain and neuroimmune signaling studies and as a pre-clinical analgesic lead.

Experimental

Conantokin-G

Conantokin-G from Conus geographus venom

Conantokin-G is a gamma-carboxyglutamate-rich cone snail peptide that antagonizes NMDA receptor activity. It has been used extensively to study excitatory neurotransmission and seizure biology.

Experimental

Mambalgin-1

Mambalgin-1 from Dendroaspis polylepis venom

Mambalgin-1 is a three-finger snake venom peptide that inhibits acid-sensing ion channels (ASICs), especially ASIC1a and ASIC1b. It is studied as a non-opioid analgesic lead with strong mechanistic value in sensory neuroscience.

Experimental

Huwentoxin-IV

Huwentoxin-IV from Selenocosmia huwena venom

Huwentoxin-IV is a spider venom peptide that potently targets voltage-gated sodium channels, with strong interest around Nav1.7. It is widely used as a tool compound for ion-channel pharmacology and analgesic discovery.

Experimental